Clinical Trial Update: Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates a Farnesyl Protein Transferase Inhibitor (FPTI) in combination with docetaxel for advanced solid tumors and has completed enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Farnesyl Protein Transferase Inhibitor (FPTI)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms | Phase 1 | Status: COMPLETED